Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

RSSL

RSSL is a specialist scientific consultancy providing unrivalled expertise in analysis, product development and training. We can help you achieve your commercial objectives in key areas such as product safety and innovation as well as meeting the demands of legislation and consumers.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

RSSL
Reading Science Centre, Whiteknights Campus, Pepper Lane, Reading, RG6 6LA, UK
+44 (0) 118 918 4000
Contact RSSL
Website

 Latest Content from PMHub 

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

Press Releases | March 3, 2022 | Avalere Health

Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...

Onyx Health Announces a “Double Hatrick” of New Appointments

Press Releases | March 3, 2022 | Onyx Health

Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

Utilising Patient Insight in Pharma Marketing

White Papers and Resources | March 3, 2022 | Dice Medical Communications

The importance in understanding the patients view point when marketing in Pharma (Article written August 30th 2021)

Office move signals new era for Berkshire agency

Press Releases | March 3, 2022 | Dice Medical Communications

Dice Medical Communications moves office due to business growth

How Ease of Access to HES Data Benefits HCPs & Key NHS Stakeholders

White Papers and Resources | March 3, 2022 | Dice Medical Communications

Article written August 27th 2021

How a Copywriter Reads a Clinical Paper

White Papers and Resources | March 2, 2022 | Dice Medical Communications

What key elements you need to consider in a clinical paper (Article written November 18th 2021)

What does HCP engagement look like in a post-Covid world?

White Papers and Resources | March 2, 2022 | Dice Medical Communications

HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

Press Releases | March 2, 2022 | Lucid Group Communications Limited

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...

Nucleus Global launches new branding as it sets its sights on the future

Press Releases | March 1, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, has announced the launch of its new brand.With over 35 years of experience providing medical communications excellence to the...

White paper: Are we prepared for the influx of CAR-Ts?

White Papers and Resources | March 1, 2022 | Inizio

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies